Article
aiCRISPRL: An Artificial Intelligence Platform for Stem Cell and Organoid Simulation with Extensive Gene Editing Capabilities
2022-06-19
Abstract excerpt
<h4>ABSTRACT</h4> CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated nuclease 9) provides powerful gene-editing tools that are applicable for gene therapy of a variety of diseases including, but not limited to cancer, rare diseases, and heart disease. In the current study, we first re-examined our artificial stem cell and organoid simulations that were generated by our litera...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 789aeca6-e4e5-5e64-bcfd-e98e51aedd6f
- DOI
- 10.1101/2022.06.18.496679
